Cargando…

Most Youth With Type 1 Diabetes in the T1D Exchange Clinic Registry Do Not Meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes Clinical Guidelines

OBJECTIVE: To assess the proportion of youth with type 1 diabetes under the care of pediatric endocrinologists in the United States meeting targets for HbA(1c), blood pressure (BP), BMI, and lipids. RESEARCH DESIGN AND METHODS: Data were evaluated for 13,316 participants in the T1D Exchange clinic r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wood, Jamie R., Miller, Kellee M., Maahs, David M., Beck, Roy W., DiMeglio, Linda A., Libman, Ingrid M., Quinn, Maryanne, Tamborlane, William V., Woerner, Stephanie E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687259/ https://www.ncbi.nlm.nih.gov/pubmed/23340893 http://dx.doi.org/10.2337/dc12-1959

Ejemplares similares

Treatable Diabetic Retinopathy Is Extremely Rare Among Pediatric T1D Exchange Clinic Registry Participants
por: Beauchamp, Giovanna, et al.
Publicado: (2016)

Factors Associated With Microalbuminuria in 7,549 Children and Adolescents With Type 1 Diabetes in the T1D Exchange Clinic Registry
por: Daniels, Mark, et al.
Publicado: (2013)

The Evolution of Hemoglobin A(1c) Targets for Youth With Type 1 Diabetes: Rationale and Supporting Evidence
por: Redondo, Maria J., et al.
Publicado: (2021)

Use of Adjuvant Pharmacotherapy in Type 1 Diabetes: International Comparison of 49,996 Individuals in the Prospective Diabetes Follow-up and T1D Exchange Registries
por: Lyons, Sarah K., et al.
Publicado: (2017)

No Summer Vacation From Diabetes: Glycemic Control in Pediatric Participants in the T1D Exchange Registry Based on Time of Year
por: Sherr, Jennifer L., et al.
Publicado: (2016)

LBSUN309 The Effect Of Prebiotics In Newly Diagnosed Youth With Type 1 Diabetes (T1D)
por: Ismail, Heba, et al.
Publicado: (2022)

Continuous glucose monitoring and glycemic control among youth with type 1 diabetes: International comparison from the T1D Exchange and DPV Initiative
por: DeSalvo, Daniel J., et al.
Publicado: (2018)

Continuous Glucose Monitoring in Patients With Type 1 Diabetes Using Insulin Injections
por: Foster, Nicole C., et al.
Publicado: (2016)

Differences in the Management of Type 1 Diabetes Among Adults Under Excellent Control Compared With Those Under Poor Control in the T1D Exchange Clinic Registry
por: Simmons, Jill H., et al.
Publicado: (2013)

Glucagon Nasal Powder: A Promising Alternative to Intramuscular Glucagon in Youth With Type 1 Diabetes
por: Sherr, Jennifer L., et al.
Publicado: (2016)

Cause or effect? A review of clinical data demonstrating beta cell dysfunction prior to the clinical onset of type 1 diabetes
por: Sims, Emily K., et al.
Publicado: (2019)

SAT107 Assessing Continuous Glucose Monitor Alarm Use By Families Of Children With Diabetes
por: Ochs, Victoria S, et al.
Publicado: (2023)

Effectiveness of Early Intensive Therapy on β-Cell Preservation in Type 1 Diabetes
por: Buckingham, Bruce, et al.
Publicado: (2013)

ISPAD Clinical Practice Consensus Guidelines 2022: Glycemic targets and glucose monitoring for children, adolescents, and young people with diabetes
por: de Bock, Martin, et al.
Publicado: (2022)

Predictors of Dyslipidemia Over Time in Youth With Type 1 Diabetes: For the SEARCH for Diabetes in Youth Study
por: Shah, Amy S., et al.
Publicado: (2017)

Overcoming Barriers to Diabetes Technology in Youth with Type 1 Diabetes and Public Insurance: Cases and Call to Action
por: Lee, Ming Yeh, et al.
Publicado: (2022)

Nutrition and Obesity in the Pathogenesis of Youth-Onset Type 1 Diabetes and Its Complications
por: March, Christine A., et al.
Publicado: (2021)

Evaluating the effect of prebiotics on the gut microbiome profile and β cell function in youth with newly diagnosed type 1 diabetes: protocol of a pilot randomized controlled trial
por: Ismail, Heba M., et al.
Publicado: (2023)

Psychosocial Needs for Newly Diagnosed Youth with Type 1 Diabetes and Their Families
por: Patton, Susana R., et al.
Publicado: (2022)

Development and delivery of a brief family behavioral intervention to support continuous glucose monitor use in young children with type 1 diabetes
por: Hilliard, Marisa E., et al.
Publicado: (2022)

Effects of Frequency of Sensor-Augmented Pump Use on HbA(1c) and C-Peptide Levels in the First Year of Type 1 Diabetes
por: Triolo, Taylor M., et al.
Publicado: (2016)

A Decade of Disparities in Diabetes Technology Use and HbA(1c) in Pediatric Type 1 Diabetes: A Transatlantic Comparison
por: Addala, Ananta, et al.
Publicado: (2021)

PCSK9 Is Increased in Youth With Type 1 Diabetes
por: Levenson, Amy E., et al.
Publicado: (2017)

Increasing Incidence of Type 1 Diabetes in Youth: Twenty years of the Philadelphia Pediatric Diabetes Registry
por: Lipman, Terri H., et al.
Publicado: (2013)

4033 Evaluating the Effect of Prebiotics on the Gut Microbiome Profile and Beta-cell Function in Newly-Diagnosed Type 1 Diabetes
por: Ismail, Heba M, et al.
Publicado: (2020)

Renal Complications and Duration of Diabetes: An International Comparison in Persons with Type 1 Diabetes
por: Dena, Mary, et al.
Publicado: (2021)

Peripheral immune circadian variation, synchronisation and possible dysrhythmia in established type 1 diabetes
por: Beam, Craig A., et al.
Publicado: (2021)

Crisis in Care: Limited Treatment Options for Type 2 Diabetes in Adolescents and Youth
por: Tamborlane, William V., et al.
Publicado: (2013)

Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes
por: Anderson, Randy L., et al.
Publicado: (2022)

57437 Effects of Prebiotics on the Gut Microbiome Profile, Beta-cell Function and Immune Markers in Newly-Diagnosed Type 1 Diabetes
por: Ismail, Heba M., et al.
Publicado: (2021)

Response to Comment on Hofer et al. International Comparison of Smoking and Metabolic Control in Patients With Type 1 Diabetes. Diabetes Care 2016;39:e177–e178
por: Hofer, Sabine E., et al.
Publicado: (2017)

Barriers to Screening: An Analysis of Factors Impacting Screening for Type 1 Diabetes Prevention Trials
por: Kinney, Mara, et al.
Publicado: (2023)

Erratum. Who Is Enrolling? The Path to Monitoring in Type 1 Diabetes TrialNet’s Pathway to Prevention. Diabetes Care 2019;42:2228–2236
por: Sims, Emily K., et al.
Publicado: (2020)

Evidence of a Strong Association Between Frequency of Self-Monitoring of Blood Glucose and Hemoglobin A(1c) Levels in T1D Exchange Clinic Registry Participants
por: Miller, Kellee M., et al.
Publicado: (2013)

Type 1 Diabetes at a Crossroads!
por: Cefalu, William T., et al.
Publicado: (2015)

Increase in Prevalence of Diabetic Ketoacidosis at Diagnosis Among Youth With Type 1 Diabetes: The SEARCH for Diabetes in Youth Study
por: Jensen, Elizabeth T., et al.
Publicado: (2021)

Response to Comment on Rickels et al. Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study. Diabetes Care 2016;39:264–270
por: Rickels, Michael R., et al.
Publicado: (2016)

Dasiglucagon, a next‐generation ready‐to‐use glucagon analog, for treatment of severe hypoglycemia in children and adolescents with type 1 diabetes: Results of a phase 3, randomized controlled trial
por: Battelino, Tadej, et al.
Publicado: (2021)

Diabetes in African American Youth: Prevalence, incidence, and clinical characteristics: the SEARCH for Diabetes in Youth Study
por: Mayer-Davis, Elizabeth J., et al.
Publicado: (2009)

Lived experience of CamAPS FX closed loop system in youth with type 1 diabetes and their parents
por: Hood, Korey K., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vv4v1ufbdjf7ar529bqa9r269t